Control group: normal rats without any IA treatment and aVNS or sham, but received balloon and wires implantation of EMG and ECG (n = 12; 6 rats were randomly picked and sacrificed for the gastric emptying test).
IA-treated group: IA-treated rats received balloon and wires implantation of EMG and ECG but not aVNS or sham (n = 12; 6 rats were randomly chosen and sacrificed for the gastric emptying test).
aVNS group: IA-treated rats received aVNS and balloon and wires implantation of EMG and ECG (6 IA-treated rats with daily aVNS).
Sham-aVNS group: IA-treated rats received sham-aVNS and balloon and wires implantation of EMG and ECG (6 IA-treated rats with daily sham-aVNS).
In order to investigate the vagal efferent pathway involved in the ameliorating effects of aVNS in IA-treated rats, we implemented another experiment including 4 groups (24 rats): (1) the IA-treated group and IA + aVNS group were similar with above experiment (n = 6); (2) IA + Subphrenic vagotomy (SV) group (6 IA-treated rats were subjected to SV without stimulation) and (3) IA + aVNS + SV group (6 IA-treated rats were subjected to SV with aVNS). The experimental protocol for these rats was similar to the other four groups of rats (